TransMedics Group, Inc.

NasdaqGM:TMDX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

Location

United States

Market Cap

USD 4.05 B

Share Price

USD 118.81

Avg Daily Volume

1,007,682

Change (1 day)

-2.52%

Change (1 year)

-31.30%

Change (YTD)

90.55%

TransMedics Group, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 21.07%

TransMedics Group, Inc. EBITDA Margin is 21.07% for the Trailing 12 Months (TTM) ending June 30, 2025, a 219.52% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

TransMedics Group, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 6.59%, a -249.13% change year over year.
TransMedics Group, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -4.42%, a -94.39% change year over year.
TransMedics Group, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -78.84%, a -3.14% change year over year.
TransMedics Group, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -81.39%, a -32.47% change year over year.